An open-label study to evaluate the safety of boceprevir or telaprvir in addition to pegylated interferon and ribavirin for the treatment of chronic Hepatitis C in patients with bleeding disorders
- Sasadeusz, Joseph, (Primary Chief Investigator (PCI))
- Audsley, Jennifer, (Chief Investigator (CI))
- Lewin, Sharon (Chief Investigator (CI))
- Strasser, Simone (Chief Investigator (CI))
- Wright, Edwina (Chief Investigator (CI))
- Tran, Huyen (Chief Investigator (CI))
- Iser, David M. (Chief Investigator (CI))
- Dunkley, Scott (Partner Investigator (PI))
Project: Research